Integrated rare variant-based risk gene prioritization in disease case-control sequencing studies

Area of Science:

• Genetics
• Genomics
• Bioinformatics

Background:

• Rare variants with major effects significantly contribute to human complex diseases.
• Sequencing-based genome-wide association studies (GWAS) are crucial for discovering these rare variants.
• Identifying disease-implicated rare variants remains a challenge, especially for complex genetic disorders.

Purpose of the Study:

• To develop and validate an integrated approach for identifying risk genes associated with rare variants in complex human diseases.
• To improve the discovery power for rare variants compared to existing methods.
• To uncover novel genetic factors contributing to diseases like congenital heart disease.

Main Methods:

• An integrated approach combining rare variant association testing with gene network and phenotype data.
• A 'discovery-driven' data integration strategy, minimizing reliance on prior disease knowledge.
• Performance evaluation through simulations and a case study on congenital heart disease.

Main Results:

• The integrated method demonstrated a 2-3 times higher performance than a widely-used rare variant association test in simulations.
• The approach successfully identified putative risk genes and rare variants in a cohort of congenital heart disease patients with 22q11.2 deletion syndrome.
• These disease-modifying variants were previously missed by conventional rare variant association tests.

Conclusions:

• The integrated approach offers a powerful and unbiased strategy for discovering rare variants and risk genes in complex diseases.
• This method has significant implications for understanding the genetic architecture of diseases and identifying novel therapeutic targets.
• The findings highlight the importance of integrating diverse biological data for comprehensive genetic discovery.